Eftychia Bellou

1.2k total citations
15 papers, 463 citations indexed

About

Eftychia Bellou is a scholar working on Physiology, Molecular Biology and Genetics. According to data from OpenAlex, Eftychia Bellou has authored 15 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 7 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in Eftychia Bellou's work include Genetic Associations and Epidemiology (7 papers), Alzheimer's disease research and treatments (7 papers) and Bioinformatics and Genomic Networks (5 papers). Eftychia Bellou is often cited by papers focused on Genetic Associations and Epidemiology (7 papers), Alzheimer's disease research and treatments (7 papers) and Bioinformatics and Genomic Networks (5 papers). Eftychia Bellou collaborates with scholars based in United Kingdom, Spain and United States. Eftychia Bellou's co-authors include Valentina Escott‐Price, John Hardy, Ganna Leonenko, Julie Williams, Joshua Stevenson‐Hoare, Rebecca Sims, Maryam Shoai, Keeley J. Brookes, Kevin Morgan and Regina H. Reynolds and has published in prestigious journals such as Brain, Annals of Neurology and Annals of the Rheumatic Diseases.

In The Last Decade

Eftychia Bellou

14 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eftychia Bellou United Kingdom 8 201 139 119 94 93 15 463
Alexander Kollhoff United States 10 185 0.9× 70 0.5× 102 0.9× 153 1.6× 27 0.3× 22 442
Miguel A. Riudavets United States 12 293 1.5× 132 0.9× 136 1.1× 116 1.2× 22 0.2× 16 522
Joshua Stevenson‐Hoare United Kingdom 8 138 0.7× 108 0.8× 53 0.4× 92 1.0× 95 1.0× 15 335
Xu Yi China 14 163 0.8× 219 1.6× 105 0.9× 50 0.5× 15 0.2× 35 590
Matt Huentelman United States 12 129 0.6× 202 1.5× 42 0.4× 84 0.9× 110 1.2× 25 474
Valeria Lifke Germany 7 468 2.3× 294 2.1× 135 1.1× 475 5.1× 96 1.0× 11 956
Kathleen Black United States 11 145 0.7× 121 0.9× 106 0.9× 57 0.6× 92 1.0× 15 457
Anne Turner Australia 9 113 0.6× 147 1.1× 33 0.3× 79 0.8× 87 0.9× 10 404
Benjamin Saef United States 7 159 0.8× 91 0.7× 51 0.4× 80 0.9× 52 0.6× 10 340
David Just Sweden 11 102 0.5× 141 1.0× 27 0.2× 50 0.5× 22 0.2× 17 379

Countries citing papers authored by Eftychia Bellou

Since Specialization
Citations

This map shows the geographic impact of Eftychia Bellou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eftychia Bellou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eftychia Bellou more than expected).

Fields of papers citing papers by Eftychia Bellou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eftychia Bellou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eftychia Bellou. The network helps show where Eftychia Bellou may publish in the future.

Co-authorship network of co-authors of Eftychia Bellou

This figure shows the co-authorship network connecting the top 25 collaborators of Eftychia Bellou. A scholar is included among the top collaborators of Eftychia Bellou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eftychia Bellou. Eftychia Bellou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Graham, Andrew, Eftychia Bellou, Janet Harwood, et al.. (2025). Human longevity and Alzheimer’s disease variants act via microglia and oligodendrocyte gene networks. Brain. 148(3). 969–984. 2 indexed citations
2.
Bellou, Eftychia, Woori Kim, Ganna Leonenko, et al.. (2025). Benchmarking Alzheimer’s disease prediction: personalised risk assessment using polygenic risk scores across various methodologies and genome-wide studies. Alzheimer s Research & Therapy. 17(1). 6–6. 1 indexed citations
3.
Leonenko, Ganna, Eftychia Bellou, Amanda Myers, et al.. (2024). Chromosome X-wide association study in case control studies of pathologically confirmed Alzheimer’s disease in a European population. Translational Psychiatry. 14(1). 358–358. 4 indexed citations
4.
Bellou, Eftychia & Valentina Escott‐Price. (2023). Are Alzheimer's and coronary artery diseases genetically related to longevity?. Frontiers in Psychiatry. 13. 1102347–1102347. 5 indexed citations
5.
Zhao, Sizheng Steven, Eftychia Bellou, Suzanne Verstappen, et al.. (2022). Association between psoriatic disease and lifestyle factors and comorbidities: cross-sectional analysis and Mendelian randomization. Lara D. Veeken. 62(3). 1272–1285. 21 indexed citations
6.
Stevenson‐Hoare, Joshua, Amanda Heslegrave, Ganna Leonenko, et al.. (2022). Plasma biomarkers and genetics in the diagnosis and prediction of Alzheimer’s disease. Brain. 146(2). 690–699. 112 indexed citations
7.
Graham, Andrew, Thomas M. Piers, Maryam Shoai, et al.. (2021). A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene. Brain. 144(12). 3727–3741. 75 indexed citations
8.
Bellou, Eftychia, Emily Baker, Ganna Leonenko, et al.. (2020). Age-dependent effect of APOE and polygenic component on Alzheimer's disease. Neurobiology of Aging. 93. 69–77. 31 indexed citations
9.
Bellou, Eftychia, Joshua Stevenson‐Hoare, & Valentina Escott‐Price. (2020). Polygenic risk and pleiotropy in neurodegenerative diseases. Neurobiology of Disease. 142. 104953–104953. 31 indexed citations
10.
Leonenko, Ganna, Maryam Shoai, Eftychia Bellou, et al.. (2019). Genetic risk for alzheimer disease is distinct from genetic risk for amyloid deposition. Annals of Neurology. 86(3). 427–435. 67 indexed citations
11.
Salih, Derviş A., Sevinç Bayram, Sebastian Guelfi, et al.. (2019). Genetic variability in response to amyloid beta deposition influences Alzheimer’s disease risk. Brain Communications. 1(1). fcz022–fcz022. 75 indexed citations
12.
Cook, Michael J., Eftychia Bellou, John Bowes, et al.. (2018). The prevalence of co-morbidities and their impact on physical activity in people with inflammatory rheumatic diseases compared with the general population: results from the UK Biobank. Lara D. Veeken. 57(12). 2172–2182. 36 indexed citations
13.
Bellou, Eftychia, Suzanne Verstappen, Michael J. Cook, et al.. (2016). AB0727 Increased Rates of Hypertension in Patients with Psoriatic Arthritis Compared To Psoriasis Alone: Results from The UK Biobank. Annals of the Rheumatic Diseases. 75. 1153–1153. 1 indexed citations
14.
Bellou, Eftychia, Suzanne Verstappen, Michael J. Cook, et al.. (2016). O02 Increased Rates of Hypertension in Patients with Psoriatic Arthritis Compared to Psoriasis Alone: Results from the Uk Biobank. Lara D. Veeken. 1 indexed citations
15.
Bellou, Eftychia, et al.. (2015). Machine learning of fatigue-related clinical features in primary Sjogren's Syndrome. 81(5). 363–364. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026